Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cara Therapeutics Inc.
DescriptionCannabinoid CB1 receptor (CNR1) and cannabinoid CB2 receptor (CNR2) agonist
Molecular Target Cannabinoid CB1 receptor (CNR1) ; Cannabinoid CB2 receptor (CNR2)
Mechanism of ActionCannabinoid CB2 receptor agonist; Cannabinoid CB1 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today